<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: December 19, 2000
(Date of earliest event reported)
CARDIMA, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-22419 94-3177883
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
47266 Benicia Street, Fremont, California 94538
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (510) 354-0300
<PAGE>
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS
Cardima, Inc. sold a portion of its patent portfolio and related
intellectual property pertaining to intravascular sensing and signal detection
and certain guiding catheters to Medtronic, Inc. for $8,000,000 in cash,
$4,000,000 of which was paid on execution of the agreement on December 19, 2000.
The balance will be paid on completion of the transfer of the property, which is
expected to take less than 45 days. Cardima received back a co-exclusive,
perpetual, fully paid license for the right to use these patents for its core
business interest, mapping and ablation. The terms of the transaction were
based on arms-length negotiations between the parties and were not based on an
appraisal or any other formal method of valuation of the property.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
Cardima, Inc. is not filing the required financial statements and pro forma
information at this time. Cardima, Inc. will file such financial statements as
an amendment to this Form 8-K no later than sixty (60) days after the date of
filing of this initial Form 8-K pursuant to Item 7 of Form 8-K.
2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: December 22, 2000
CARDIMA, INC.
By /s/ Ronald E. Bourquin
-----------------------
Ronald E. Bourquin
Vice President and
Chief Financial Officer
3
